Corcept Therapeutics (CORT) Change in Acquisitions & Divestments (2017 - 2026)
Corcept Therapeutics' Change in Acquisitions & Divestments history spans 10 years, with the latest figure at $57.1 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 49.08% to $57.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $334.6 million, a 26.64% decrease, with the full-year FY2025 number at $389.6 million, down 5.64% from a year prior.
- Change in Acquisitions & Divestments hit $57.1 million in Q1 2026 for Corcept Therapeutics, down from $132.0 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for CORT hit a ceiling of $207.5 million in Q1 2023 and a floor of $42.1 million in Q1 2022.
- Historically, Change in Acquisitions & Divestments has averaged $89.4 million across 5 years, with a median of $79.4 million in 2022.
- Biggest five-year swings in Change in Acquisitions & Divestments: surged 392.5% in 2023 and later crashed 71.23% in 2025.
- Tracing CORT's Change in Acquisitions & Divestments over 5 years: stood at $79.4 million in 2022, then crashed by 40.83% to $47.0 million in 2023, then surged by 70.92% to $80.3 million in 2024, then skyrocketed by 64.37% to $132.0 million in 2025, then tumbled by 56.78% to $57.1 million in 2026.
- Business Quant data shows Change in Acquisitions & Divestments for CORT at $57.1 million in Q1 2026, $132.0 million in Q4 2025, and $52.0 million in Q3 2025.